SEC Form 4 · accession 0001225208-16-029417
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen Prange
Officer — SVP&Pres, Uro & Pelvic Health
Period of report
Mar 8, 2016
Accepted (ET)
Mar 8, 2016 · 4:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 8, 2016 | S | 14,747 | $17.2746 | D | 38,395 | D | |
| Common Stock | holding | — | — | — | 1,000 | I | By Parent |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.